Últimas noticias sobre Cemtrex (NASDAQ:CETX) Bolsa

Cemtrex

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

Earnings

News

Pre-Market Outlook

Markets

AMBO

CETX

CMPO

SGMO

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este martes: EH, SGMO, CETX, CMPO y AMBO.

5 acciones en el foco este martes: EH, SGMO, CETX, CMPO y AMBO

Cemtrex Inc

The market just wrapped up a lackluster February, with <a href="https://www.benzinga.com/topic/s-p-500-index">the S&amp;P 500 Index</a> slipping 1.4% amid economic uncertainty, sticky inflation, and signs of retail buyer fatigue.
But according to Adam Turnquist, Chief Technical Strategist at LPL Financial, seasonal trends suggest that March could bring a shift in momentum, making it a key period for portfolio adjustments.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43861187/sp-500-vs-russell-2000-are-small-caps-set-for-a-breakout">S&amp;P 500 Vs. Russell 2000: Are Small Caps Set For A Breakout?</a>
<h2 class="wp-block-heading">March's Historical Strength Warrants Tactical Adjustments</h2>
Since 1950, the S&amp;P 500 has posted an average March gain of 1.1%, finishing positive 65% of the time. Historically, momentum tends to carry into April, signaling a potential rebound. This seasonality could present a chance for investors to reassess sector allocations and position themselves ahead of a historically favorable period.
Beyond seasonality, macroeconomic headwinds remain in focus. Inflation data continues to drive market sentiment, and Federal Reserve policy expectations could further dictate investor positioning. 
However, Turnquist notes that past trends suggest investors who rotate into outperforming sectors early in the month could benefit from the seasonal upswing.
<h2 class="wp-block-heading">Where To Position: Sector Standouts And Weak Spots</h2>
Turnquist highlights three sectors with historical March outperformance: real estate, utilities, and consumer discretionary. Since 2002, real estate has averaged a 2.0% gain in March, while utilities and consumer discretionary stocks have delivered 1.7% average gains since 1990.
To capitalize on these seasonal trends, investors may look to the Real Estate Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>) and the Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) for defensive positioning, while the Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) could benefit from renewed market momentum. These exchange-traded funds (ETFs) offer broad exposure to sectors that have historically outperformed during this period.
Conversely, healthcare has underperformed in March, with an average return of just 0.5%. Investors looking to rebalance may consider reducing exposure to healthcare stocks or reallocating funds toward historically stronger sectors.
<h2 class="wp-block-heading">A Prime Moment For Portfolio Adjustments</h2>
With February's pullback offering a reset, March presents a prime opportunity for investors to optimize portfolios ahead of what has historically been a seasonally strong period. 
While macroeconomic risks persist, historical patterns suggest that a tactical shift into leading sectors could offer a strategic advantage.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44074852/sp-500-correction-overdue-will-the-markets-sideways-dance-turn-into-a-tumble-focus-on-balance-and-diversification-recommends-analyst">S&amp;P 500 Correction &#8216;Overdue:&#8217; Will The Market&#8217;s &#8216;Sideways&#8217; Movement Turn Into A Tumble? &#8216;Focus On Balance And Diversification,&#8217; Says Analyst</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Long Ideas

Sector ETFs

Broad U.S. Equity ETFs

Trading Ideas

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

March Market Trends Signal 3 Sectors To Watch As Seasonal Strength Builds

WIIM

APA Corp shares are trading lower after Susquehanna cut its price target on the stock from $33 to $31.

Exelixis's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NYSE">EXEL</a>) short percent of float has risen 26.74% since its last report. The company recently reported that it has 16.15 million shares sold short, which is 7.82% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.78 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Exelixis Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741030239_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Exelixis has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Exelixis's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Exelixis's peer group average for short interest as a percentage of float is 5.34%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

EXEL

Peering Into Exelixis's Recent Short Interest

Element Solutions's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESI#NYSE">ESI</a>) short percent of float has risen 5.48% since its last report. The company recently reported that it has 1.72 million shares sold short, which is 0.77% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.21 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Element Solutions Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741030234_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Element Solutions has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Element Solutions's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Element Solutions's peer group average for short interest as a percentage of float is 3.52%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What's Driving the Market Sentiment Around Element Solutions?

Tetra Tech's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NYSE">TTEK</a>) short percent of float has risen 65.83% since its last report. The company recently reported that it has 7.91 million shares sold short, which is 3.3% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.13 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Tetra Tech Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741030229_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Tetra Tech has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Tetra Tech's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Tetra Tech's peer group average for short interest as a percentage of float is 6.47%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

TTEK

What Does the Market Think About Tetra Tech?

Li Auto Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) shares are trading lower by 10.4% to $27.53 during Monday&#8217;s session amid weakness in Chinese EV stocks. Weakness may be in anticipation of U.S. tariffs, <a href="https://www.benzinga.com/news/global/25/02/44010093/trumps-plan-for-canada-mexico-china-tariffs-to-start-march-4-could-shake-stock-market">expected to begin Tuesday</a>. Potential tariffs raise concerns over higher production costs and potential barriers to Li Auto's global market ambitions.
What To Know: As a Chinese EV maker, Li Auto relies on global supply chains, including semiconductor and battery components. Increased costs could pressure margins or lead to higher consumer prices. Additionally, trade tensions may deter American buyers from considering Chinese-made vehicles.
Read Also: <a href="https://www.benzinga.com/news/25/03/44081077/why-nokia-nok-shares-are-rising">Why Nokia Shares Are Rising</a>
Investors may worry that China may retaliate, further complicating Li Auto's production. The broader <a href="https://www.benzinga.com/money/best-electric-vehicle-stocks">EV sector</a>, already dealing with supply chain disruptions, faces new uncertainties.
Unless Li Auto finds ways to offset higher costs, such as by localizing supply chains, its growth prospects may be impacted. The market also remains cautious as geopolitical tensions escalate ahead of the tariff's implementation.
Read Also: <a href="https://www.benzinga.com/tech/25/03/44070271/li-auto-nio-deliveries-rise-on-year-despite-monthly-dips-xpeng-records-570-annual-growth">Li Auto, Nio Deliveries Rise On-Year Despite Monthly Dips: XPeng Records 570% Annual Growth</a>
<h2 class="wp-block-heading">How To Buy LI Stock</h2>
By now you're likely curious about how to participate in the market for Li Auto &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Li Auto, which is trading at $27.29 as of publishing time, $100 would buy you 3.66 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.

Why Li Auto Stock Is Down 10% Today

MicroCloud Hologram, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) shares are trading higher on Monday after the company announced a multi-million dollar investment in cryptocurrency, blockchain <a href="https://www.benzinga.com//node/44075010">and quantum computing.</a>
What To Know: MicroCloud announced a $200 million investment in Bitcoin and cryptocurrency-related securities derivatives. The company also revealed plans to utilize its $303 million cash reserves for derivatives investments and technology development in fields such as blockchain, quantum computing, quantum holography and AI-powered AR. 
The investment in cryptocurrency will be incorporated into MicroCloud&#8217;s capital reserve strategy with the goal of enhancing the company&#8217;s financial stability and long-term growth potential through diversified investments.
Related Link: <a href="https://www.benzinga.com/25/03/44084945/apogee-therapeutics-investigational-atopic-dermatitis-potential-shows-strong-tolerability-extended-half-life-in-early-trial">Apogee Therapeutics&#8217; Investigational Atopic Dermatitis Potential Shows Strong Tolerability, Extended Half-Life in Early Trial</a>
HOLO Price Action: At the time of writing, MicroCloud stock is trading 6.69% higher at $1.04, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: This illustration was generated using artificial intelligence via Midjourney.

Movers

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

What's Going On With MicroCloud Hologram Shares Monday?

Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) shares are trading higher Monday following reports suggesting NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) are performing manufacturing tests <a href="https://www.benzinga.com/25/03/44070969/former-intel-ceo-craig-barrett-warns-that-splitting-the-company-would-be-a-costly-mistake-a-far-better-move-might-be-to-fire-the-intel-board-and-rehire-pat-gelsinger">with the company</a>.
What To Know: Chip designers Nvidia and Broadcom have been doing manufacturing testing with Intel&#8217;s 18A manufacturing process, suggesting the chipmaker could be in the running for manufacturing contracts, per Reuters.
Sources familiar with the matter reportedly said the pair of tests indicate the companies are getting closer to making a decision on manufacturing. Intel has not yet announced a prominent chip designer customer, so any announcement involving Nvidia or Broadcom could be huge for Intel. Intel shares surged in early trading before pulling back. The stock was last up about 1%.
The report indicates that Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) is also evaluating whether Intel&#8217;s manufacturing process will be the best path forward. It&#8217;s not clear if AMD has engaged in any testing with Intel to date.
&#8220;We don&#8217;t comment on specific customers but continue to see strong interest and engagement on Intel 18A across our ecosystem,&#8221; an Intel spokesperson reportedly said.
Check This Out: <a href="https://www.benzinga.com/25/03/44070969/former-intel-ceo-craig-barrett-warns-that-splitting-the-company-would-be-a-costly-mistake-a-far-better-move-might-be-to-fire-the-intel-board-and-rehire-pat-gelsinger">&#8216;Fire The Intel Board,&#8217; Says Former CEO Craig Barrett As He Pushes Back On Breakup Plans, Urges Focus On Chipmaking Wins</a>
Intel&#8217;s 18A manufacturing process is capable of producing advanced AI processors and complex chips. Testing can take months to complete. The report indicates that it&#8217;s not clear when the tests began.
Former Intel CEO Pat Gelsinger announced his retirement in December after reportedly being forced out by the board. Intel shares are up nearly 20% year-to-date on hopes the company could lean into more aggressive strategy changes under new leadership.
INTC Price Action: <a href="http://benzinga.com/quote/intc">Intel shares</a> initially surged above the $25 level in early trading before pulling back. The stock was up 0.65% at $23.90 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

AVGO

INTC

NVDA

What's Going On With Intel Stock Monday?

U.S. Sec Of The Interior Doug Burgum Says: Alaska A Huge Priority For Rare Earths, Oil, Gas

BioXcel Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTAI#NASDAQ">BTAI</a>) shares are trading higher Monday following news that the U.S. Food and Drug Administration has concluded its inspection of a site involved in the <a href="https://ir.bioxceltherapeutics.com/news-releases/news-release-details/bioxcel-therapeutics-announces-fda-closed-its-inspection-site">company's Phase 3</a> TRANQUILITY II trial.
What To Know: The trial evaluates BXCL501 for the acute treatment of agitation associated with Alzheimer's dementia. The FDA released an Establishment Inspection Report and designated the site with a &#8220;Voluntary Action Indicated&#8221; status under 21 C.F.R.20.64(d)(3), signaling that while some minor issues may have been noted, they do not require regulatory action.
The company has also received FDA feedback on the protocol for its TRANQUILITY In-Care Phase 3 trial, which is set to evaluate BXCL501 for agitation in Alzheimer's patients residing in care facilities. The TRANQUILITY In-Care trial will assess the efficacy and safety of a 60 mcg dose of BXCL501 over 12 weeks in patients with mild to severe Alzheimer's-related dementia.
BTAI Price Action: BioXcel shares were up 117.1% at $4.68 at the time of writing, according to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072624&amp;t=be2bearmibe3na1">Benzinga pro.</a>
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="521" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03131335/Screenshot-2025-03-03-at-13.13.09-1024x521.png" alt="" class="wp-image-806623" style="width:414px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03131335/Screenshot-2025-03-03-at-13.13.09-1024x521.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03131335/Screenshot-2025-03-03-at-13.13.09-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03131335/Screenshot-2025-03-03-at-13.13.09-768x391.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/03131335/Screenshot-2025-03-03-at-13.13.09.png 1523w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/03/44084997/tesla-rebounds-while-tariffs-weigh-on-manufacturing-whats-driving-markets-monday">Tesla Rebounds While Tariffs Weigh On Manufacturing: What&#8217;s Driving Markets Monday?</a></li>
</ul>
Image Via Shutterstock.

BTAI

BioXcel Shares Are Up Today: What's Going On?

ETFs with <a href="https://www.benzinga.com/etfs">significant exposure to Chinese stocks</a> surged on Monday, as stronger-than-expected manufacturing data and expectations of fresh stimulus from Beijing boosted investor confidence. The gains helped recoup some of last week's losses, which were driven by economic uncertainty and trade tensions between <a href="https://www.benzinga.com/markets/25/02/43938959/trump-targets-chinas-tech-sector-with-stricter-biden-era-chip-curbs-it-will-backfire-says-beijing">China and the U.S</a>. 
Several ETFs tracking Chinese stocks inched up in response to the market rebound.
ETFs To Watch
KraneShares CSI China Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NYSE">KWEB</a>) Gained 0.6% at 12:51 pm EST as Chinese tech stocks rebounded amid optimism about a consumer demand recovery. Alibaba Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) is one of the fund&#8217;s top holdings.
GraniteShares 2x Long BABA Daily ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BABX#NASDAQ">BABX</a>): Mirrored Alibaba's rebound as investors anticipated stimulus-driven consumer spending growth and gained 2.3% as of 12:51 pm EST.
SPDR S&amp;P China ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GXC#NYSE">GXC</a>): Gained as investor sentiment improved toward high-growth technology stocks listed on China's Star Market. Alibaba holds one of the premium positions in the fund&#8217;s holdings.
Also Read: <a href="https://www.benzinga.com/25/02/44040003/alibaba-expands-ai-workforce-while-deepseek-slashes-model-prices-in-market-battle">Alibaba Expands AI Intern Workforce While DeepSeek Slashes Model Prices in Market Battle</a>
Market Rebound Amid Trade War Concerns
Hong Kong's benchmark Hang Seng Index rose 1.2% by lunch break, recovering from Friday's biggest decline in four months, while the Hang Seng Tech Index gained 0.7%. On the mainland, the blue chip CSI300 Index added 0.5%, and the Shanghai Composite Index climbed 0.3%, reversing some of Friday's 2% drop.
The rebound came after both official and private-sector surveys showed China's <a href="https://www.cnbc.com/2025/03/03/china-february-caixin-pmi.html">manufacturing </a>activity expanded at the fastest pace in three months in February. Higher purchase volumes and rising new orders contributed to stronger industrial production, easing investor concerns about the country's economic strength.
Despite the moderate gains, market sentiment remained cautious as both China and the U.S. prepared to impose additional tariffs on each other. President Donald Trump announced an additional 10% tariff on all Chinese imports. In response, China is expected to implement countermeasures, likely targeting American agricultural exports, according to reports from Global Times.
However, analysts at Bank of America noted that these moves are likely negotiation tactics rather than signals of an impending full-scale trade war. &#8220;We think these moves are still tactics to put more bargaining chips on the table before negotiations take place,&#8221; they wrote in a research note.
Stimulus Expectations
Investors are now closely watching the &#8220;Two Sessions&#8221; meetings set to begin on Tuesday, where Beijing is expected to announce fresh economic stimulus measures. Policymakers are likely to maintain China's economic growth <a href="https://www.bloomberg.com/news/articles/2025-03-02/xi-prepares-to-unveil-china-stimulus-plan-as-trade-war-heats-up?sref=TBDibEcD">target </a>at around 5% while outlining a budget deficit of 4% of GDP, according to Bloomberg.
Despite cautious investor expectations regarding the parliamentary meetings, Goldman Sachs analysts highlighted that policy support aimed at boosting domestic demand could lead to further stock market gains. Historically, stimulus measures have disproportionately benefited high-quality, discounted Chinese stocks, making ETFs a preferred vehicle for capitalizing on market shifts.
Alibaba And Blue-Chip Stocks In Focus
Alibaba Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) remains a key focus for investors as it represents both China's growing technology sector and consumer spending trends. As economic stimulus measures trickle down, Alibaba and similar blue-chip stocks are poised to be among the first to attract fresh capital. 
Also, last week, Alibaba made its video and image-generating AI model, Wan 2.1, <a href="https://www.benzinga.com/25/02/43970279/alibaba-and-deepseek-intensify-ai-showdown-challenging-openai-and-nvidias-market-dominance">publicly available on ModelScope and HuggingFace</a> for academic, research, and commercial use. It has committed $53 billion over three years to enhance its AI and cloud infrastructure. Additionally, Alibaba CEO Eddie Wu met Chongqing's party secretary to discuss potential AI collaborations. These developments have sent Alibaba on a rally.
Investors eager to capitalize on the market&#8217;s resurgence may find opportunities in ETFs that provide broad exposure to China's leading companies. However, trade tensions and policy announcements in the coming weeks will likely determine the sustainability of this rebound.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/03/44085268/market-mayhem-5-etfs-that-soared-amid-volatility-last-week">Market Mayhem: 5 ETFs That Soared Amid Volatility Last Week</a></li>
</ul>
Photo: Shutterstock

Emerging Market ETFs

BABA

BABX

KSTR

KWEB

YINN

3 China-Focused ETFs To Watch As Stronger Manufacturing Data, Stimulus Hopes Boost Sentiment

Deep-pocketed investors have adopted a bullish approach towards Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CVX usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 16 extraordinary options activities for Chevron. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 43% bearish. Among these notable options, 5 are puts, totaling $307,850, and 11 are calls, amounting to $2,773,712.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $170.0 for Chevron over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Chevron stands at 2878.79, with a total volume reaching 12,242.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Chevron, situated within the strike price corridor from $100.0 to $170.0, throughout the last 30 days.
<h3>Chevron 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741029356_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$2.12</td>
<td>$2.01</td>
<td>$2.02</td>
<td>$170.00</td>
<td>$2.0M</td>
<td>1.1K</td>
<td>10.0K</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$15.55</td>
<td>$15.25</td>
<td>$15.25</td>
<td>$150.00</td>
<td>$228.7K</td>
<td>1.2K</td>
<td>216</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$9.9</td>
<td>$9.85</td>
<td>$9.85</td>
<td>$165.00</td>
<td>$172.3K</td>
<td>1.8K</td>
<td>236</td>
</tr>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$4.1</td>
<td>$3.9</td>
<td>$4.05</td>
<td>$155.00</td>
<td>$124.7K</td>
<td>915</td>
<td>398</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$61.05</td>
<td>$59.5</td>
<td>$59.66</td>
<td>$100.00</td>
<td>$71.5K</td>
<td>133</td>
<td>12</td>
</tr>
</tbody>
</table>

<h3>About Chevron</h3>
Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.1 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.8 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2023 stood at 11.1 billion barrels of oil equivalent, including 6.0 billion barrels of liquids and 30.4 trillion cubic feet of natural gas.
Following our analysis of the options activities associated with Chevron, we pivot to a closer look at the company's own performance.
<h3>Chevron's Current Market Status</h3>
<ul>
<li>Trading volume stands at 4,164,384, with CVX's price down by -2.84%, positioned at $154.12.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 53 days.</li>
</ul>
<h3>What Analysts Are Saying About Chevron</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $176.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Chevron, which currently sits at a price target of $184. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Chevron with a target price of $194. 
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Hold rating on Chevron with a target price of $160. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Chevron, which currently sits at a price target of $171. 
&#x2A; In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $175. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Chevron options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

Smart Money Is Betting Big In CVX Options

Financial giants have made a conspicuous bullish move on Astera Labs. Our analysis of options history for Astera Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) revealed 13 unusual trades.
Delving into the details, we found 53% of traders were bullish, while 38% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $1,585,931, and 4 were calls, valued at $214,495.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $55.0 to $140.0 for Astera Labs over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Astera Labs's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Astera Labs's significant trades, within a strike price range of $55.0 to $140.0, over the past month.
<h3>Astera Labs Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741029351_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$10.4</td>
<td>$9.9</td>
<td>$10.0</td>
<td>$55.00</td>
<td>$500.0K</td>
<td>39</td>
<td>1.0K</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$10.0</td>
<td>$9.9</td>
<td>$10.0</td>
<td>$55.00</td>
<td>$391.0K</td>
<td>39</td>
<td>391</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$2.85</td>
<td>$1.9</td>
<td>$2.65</td>
<td>$67.00</td>
<td>$157.0K</td>
<td>74</td>
<td>9</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$15.8</td>
<td>$15.5</td>
<td>$15.75</td>
<td>$65.00</td>
<td>$149.6K</td>
<td>5.5K</td>
<td>95</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$16.0</td>
<td>$15.9</td>
<td>$16.0</td>
<td>$75.00</td>
<td>$139.2K</td>
<td>276</td>
<td>87</td>
</tr>
</tbody>
</table>

<h3>About Astera Labs</h3>
Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform integrates semiconductor technology, microcontrollers, sensors, and software to enhance performance, scalability, and data management. The company offers products such as integrated circuits (ICs), boards, and modules, catering to hyperscalers and system OEMs. The company's solutions focus on data, network, and memory management in AI-driven platforms.
In light of the recent options history for Astera Labs, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Astera Labs's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 4,320,063, the ALAB's price is down by -6.25%, now at $69.7. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 82 days.</li>
</ul>
<h3>What Analysts Are Saying About Astera Labs</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $132.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $140. 
&#x2A; An analyst from Craig-Hallum persists with their Buy rating on Astera Labs, maintaining a target price of $125. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Astera Labs, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

ALAB

Astera Labs's Options Frenzy: What You Need to Know

Investors with a lot of money to spend have taken a bullish stance on SolarEdge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SEDG, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 10 uncommon options trades for SolarEdge Technologies.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 40%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $110,620, and 7 are calls, for a total amount of $1,276,821.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $2.5 to $80.0 for SolarEdge Technologies over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for SolarEdge Technologies options trades today is 649.0 with a total volume of 3,594.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for SolarEdge Technologies's big money trades within a strike price range of $2.5 to $80.0 over the last 30 days.
<h3>SolarEdge Technologies Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741029346_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SEDG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$13.1</td>
<td>$12.95</td>
<td>$12.95</td>
<td>$2.50</td>
<td>$259.0K</td>
<td>1.8K</td>
<td align="right">985</td>
</tr>
<tr>
<td>SEDG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$12.95</td>
<td>$12.9</td>
<td>$12.95</td>
<td>$2.50</td>
<td>$259.0K</td>
<td>1.8K</td>
<td align="right">785</td>
</tr>
<tr>
<td>SEDG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$13.0</td>
<td>$12.95</td>
<td>$12.95</td>
<td>$2.50</td>
<td>$259.0K</td>
<td>1.8K</td>
<td align="right">585</td>
</tr>
<tr>
<td>SEDG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$13.0</td>
<td>$12.95</td>
<td>$13.0</td>
<td>$2.50</td>
<td>$176.3K</td>
<td>1.8K</td>
<td align="right">236</td>
</tr>
<tr>
<td>SEDG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$13.1</td>
<td>$12.95</td>
<td>$13.0</td>
<td>$2.50</td>
<td>$130.0K</td>
<td>1.8K</td>
<td align="right">100</td>
</tr>
</tbody>
</table>

<h3>About SolarEdge Technologies</h3>
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.
Following our analysis of the options activities associated with SolarEdge Technologies, we pivot to a closer look at the company's own performance.
<h3>SolarEdge Technologies's Current Market Status</h3>
<ul>
<li>Trading volume stands at 2,867,751, with SEDG's price down by -3.34%, positioned at $15.94.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 65 days.</li>
</ul>
<h3>What Analysts Are Saying About SolarEdge Technologies</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $18.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Buy rating on SolarEdge Technologies, which currently sits at a price target of $31. 
&#x2A; An analyst from Jefferies has decided to maintain their Underperform rating on SolarEdge Technologies, which currently sits at a price target of $12. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Underweight rating on SolarEdge Technologies with a target price of $10. 
&#x2A; In a positive move, an analyst from Morgan Stanley has upgraded their rating to Equal-Weight and adjusted the price target to $18. 
&#x2A; An analyst from UBS persists with their Neutral rating on SolarEdge Technologies, maintaining a target price of $22. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for SolarEdge Technologies, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

SEDG

Spotlight on SolarEdge Technologies: Analyzing the Surge in Options Activity

Retailer Target Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) could highlight strong Black Friday sales and the impact tariffs could have on consumers when the company reports fourth-quarter financials before <a href="https://www.benzinga.com/earnings">market open Tuesday.</a>
Here are the analyst estimates and commentary, plus key items to watch ahead of the report.
Earnings Estimates: Analysts expect Target to report fourth-quarter revenue of $30.84 billion. That&#8217;s down from $31.92 billion in last year's fourth quarter, according to data<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent030325&amp;t=be2bearmibe3na1"> from Benzinga Pro.</a>
The company has missed analyst estimates for revenue in two straight quarters. It beat estimates in six of the last 10 quarters overall.
Analysts expect Target to report fourth-quarter earnings per share of $2.26, down from $2.98 in last year's fourth quarter. The company missed analyst estimates for earnings per share in one straight quarter while beating estimates in six of the last 10 quarters.
Target's <a href="https://www.benzinga.com/news/earnings/24/11/42085436/target-q3-earnings-supply-chain-chaos-hits-bottomline-slashes-annual-profit-outlook-stock-tanks">guidance for the fourth quarter</a> calls for earnings per share to be in a range of $1.85 to $2.45.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/02/44041104/how-to-earn-500-a-month-from-target-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Target Stock Ahead Of Q4 Earnings</a>
What Analysts Are Saying: Target previously reported holiday sales growth of +2.8%, but maintained its earnings per share range, which could suggest a heavier impact from promotions and discounts, Truist analyst Scot Ciccarelli said in a new investor note.
The analyst has a Hold rating and $134 price target. Target's first quarter also appears to be off to a slow start, the analyst added.
"We also think there is a chance that the company could pursue significant price investments (which we believe is needed) to improve their competitive pricing and drive longer-term share gains," Ciccarelli said.
The analyst said holiday sales growth was in-line with investor expectations and that is the assumption for the fourth quarter.
"Based on 2 years of sluggish sales performance and what appears to be a soft start to 1Q25, we think the company will likely guide comps towards a 0% to +2% range."
Ciccarelli said competitive pressure from Amazon.com and Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) "continue to mount" for Target.
"We remain cautious on TGT given continued share pressures and think that the company may need to accelerate their pricing investments to improve its competitive positioning."
Goldman Sachs analyst Kate McShane maintained a Buy rating and raised the price target on Target stock from $164 to $166<a href="https://www.benzinga.com/25/01/43102000/target-the-bull-vs-bear-case-for-2025"> in January.</a>
The analyst said Target underperformed other retailers in 2024, but the company's higher mix of discretionary products could help in the future.
"We also think TGT can benefit over time from leveraging its strong fulfillment model and its alternative revenue streams, including Roundel (advertising), Target Circle (membership), and Target Plus (marketplace)," McShane said.
The analyst said Target stock had "limited downside potential" at the time.
Here are other recent<a href="https://www.benzinga.com/quote/TGT/analyst-ratings"> analyst ratings on Target </a>and their price targets:
<ul>
<li>JPMorgan: Maintained Neutral rating, raised price target from $139 to $146</li>
<li>Bernstein: Maintained Market Perform rating, raised price target from $139 to $142</li>
<li>Guggenheim: Maintained Buy rating, raised price target from $145 to $155</li>
</ul>
Key Items to Watch: A recent <a href="https://www.placer.ai/blog/visitation-trends-and-shopping-behaviors-at-walmart-target">report </a>from Placer.ai showed that Target store visits were up 1.0% in November, down 1.3% in December and up 3.6% in January, which could signal improved sales for the first quarter.
The same report recently showed Walmart's foot traffic patterns matching up closely with the company's comparable sales growth for its<a href="https://www.benzinga.com/news/earnings/25/02/43846469/walmart-q4-earnings-shine-but-soft-fy26-outlook-disappoints-street"> recently reported quarter.</a>
While Walmart is a rival, data from Placer.ai shows that Target has customers with higher median household income, has a larger share of repeat monthly visitors and a higher market share of shopping from households with children.
The quarterly results and comparison to recent results from Walmart, who beat analyst estimates for revenue and earnings per share, could show if higher-income shoppers are struggling more or less than lower-income shoppers.
Target's fourth-quarter results will include Black Friday and holiday shopping sales. The company's partnership with Taylor Swift on an<a href="https://www.benzinga.com/general/entertainment/24/12/42351922/trump-predicted-taylor-swift-sales-would-drop-target-data-shows-over-800k-sold"> exclusive Eras Tour book </a>saw lines outside stores and strong sales over the Black Friday shopping holiday.
In the third quarter, Target highlighted Beauty, Food &amp; Beverage and Essentials as sectors seeing strong year-over-year growth.
Investors and analysts will be looking for commentary on what sectors are seeing strong sales and how the future impact of tariffs on certain goods could impact the retail giant.
Price Action: Target stock is up 0.3% to $124.56 on Monday versus a 52-week trading range of $120.21 to $181.86. Target stock is down 9.2% year-to-date in 2025 and down 17.2% over the past year.
Compare that to Walmart stock, which trades at $98.11 versus a 52-week trading range of $58.40 to $105.30. Walmart stock is up 9.0% year-to-date in 2025 and up 65.4% over the past year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/retail-sales/25/02/43977330/target-and-champion-launch-exclusive-activewear-line">Target And Champion Launch Exclusive Activewear Line</a></li>
</ul>
Image: Shutterstock

Analyst Color

Price Target

Previews

Reiteration

Analyst Ratings

Target Q4 Earnings Preview: Why One Analyst Remains 'Cautious' On Retailer After Walmart's Report

Contracts

Politics

General

TSLA

Democratic Senator Blumenthal Asks State Department To Answer Questions On Reported Plan To Purchase Tesla Cybertrucks

AMRC

Ameresco shares are trading lower. The company announced the acquisition of ASA Controls.

CNH Industrial shares are trading lower after Baird downgraded the stock from Outperform to Neutral and cut its price target from $16 to $15.

On Monday, AbbVie&nbsp;Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) and Gubra A/S announced a license agreement to develop GUB014295, a long-acting amylin analog for obesity. GUB014295 is currently in a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44069717/abbvie-and-gubra-announce-license-agreement-to-develop-an-amylin-analog-for-the-treatment-of-obesi" rel="noreferrer noopener">Phase 1 clinical trial</a>.
&#8220;Our partnership with Gubra marks our entry into the obesity field, offering a compelling opportunity based on the potential to address patient needs while also fostering long-term growth for our company,&#8221; said&nbsp;Robert Michael, CEO of AbbVie.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/01/43403416/is-big-pharma-about-to-win-goldman-sachs-weighs-in-on-340b-and-medicaid-shifts" rel="noreferrer noopener">Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts</a>
A potential long-acting amylin analog, GUB014295 is an agonist that specifically activates amylin and calcitonin receptors.
Amylin, a satiety hormone, has been identified as a potential therapeutic target for obesity, given its role in activating signals to the brain that result in appetite suppression and the reduction of food intake while also acting as an inhibitory signal to delay gastric emptying.&nbsp;
Under the terms of the agreement, AbbVie will lead the development and commercialization activities of GUB014295 globally.
Gubra will receive&nbsp;$350 million&nbsp;in total upfront payment and be eligible to receive up to&nbsp;$1.875 billion&nbsp;in development, commercial and sales milestone payments with tiered royalties on global net sales.
William Blair analyst Matt Phipps writes, &#8220;We believe this transaction highlights a growing interest in amylin agonists (and particularly dual amylin/calcitonin receptor agonists, or DACRAs) as a next wave of obesity assets, particularly for companies looking to break into the field despite being well behind GLP-1 leaders Eli Lilly And Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) and Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>).&#8221;
The analyst highlights a key question is whether AbbVie will develop GUB014295 as a standalone treatment, offering a milder weight loss option for those who cannot tolerate or do not respond to GLP-1/GIP agonists.
Alternatively, the company may combine it with GLP-1/GIP drugs like Novo Nordisk's CagriSema for greater weight loss. Investors are also interested in whether AbbVie plans to expand further in the obesity market through new business deals.
Price Action: ABBV stock is up 0.84% at $210.78 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44080418/trimble-and-stmicroelectronics-launch-precision-positioning-tech-for-iot-applications" target="_blank" rel="noreferrer noopener">Trimble, STMicroelectronics Launch Precision Positioning Tech For IoT Applications</a></li>
</ul>
Photo via Shutterstock.

Biotech

Large Cap

Health Care

ABBV

GUBRF

AbbVie Becomes Another Big Pharma To Enter Obesity Treatment Race

<a href="https://www.bloomberg.com/news/articles/2025-03-03/saudi-s-pif-to-anchor-new-gulf-focused-goldman-sachs-funds" title="https://www.bloomberg.com/news/articles/2025-03-03/saudi-s-pif-to-anchor-new-gulf-focused-goldman-sachs-funds">https://www.bloomberg.com/news/articles/2025-03-03/saudi-s-pif-to-anchor-new-gulf-focused-goldman-sachs-funds</a>

Global

'Saudi's PIF To Anchor New Gulf-Focused Goldman Sachs Funds; GSAM Funds To Target Private Credit, Public Equity In Region; Wall Street Titans Increasingly Expand Presence In Middle East' - Bloomberg News

Press Releases

Cemtrex to Complete 100% Acquisition of Vicon Industries

Cemtrex Announces Integration of AI Armed Person Detection Feature in Vicon NEXT Cameras

Cemtrex's Advanced Industrial Services Awarded Two Contracts Totaling $6.7 Million from Derry Township Municipal Authority

Cemtrex's Vicon Announces New Partnership with AI Chipmaker Hailo for its New Modular Camera System, NEXT™

Cemtrex Regains Compliance with NASDAQ Listing Requirement

Cemtrex's Vicon Industries Secures $10.4 Million Valerus Expansion Order from State Government Corrections Customer

Cemtrex Reports Fourth Quarter and Full Fiscal Year 2024 Financial Results

Cemtrex Regains Compliance with NASDAQ Stockholders' Equity Requirement

Cemtrex Reports First Quarter Fiscal Year 2025 Financial Results

Cemtrex's Vicon Subsidiary Secures $1.2M Order for Border Protection Deployment in Texas

Comments

Cemtrex

Noticias

Últimas noticias sobre Cemtrex (NASDAQ:CETX) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL